{"name":"iBio, Inc.","slug":"ibio-inc","ticker":"","exchange":"","domain":"ibio.com","description":"iBio, Inc. is a biotechnology company focused on the discovery and development of novel biologics for the treatment of various diseases. The company's lead candidate, IBIO-600, is currently in Phase 1 clinical trials.","hq":"","founded":0,"employees":"N/A","ceo":"","sector":"Pharma / Biotech","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMikwFBVV95cUxQemFXWE45b3NDLTNIVHNTMUlVQ2Vqb2NWM1lpc0lpYXY3YzBjb2psWXpaV2lvOUdUNDRPOFJRU2xsdlQyT1lveWdaUC0tYmpZSUU3c09RbHVrS3lxMjVieUFkMWpzZUFSN3JWbUhla3RJWkw2NFRfaURoblhYWWR1eFlLSHIyaWlXc2N3VENURklnSmM?oc=5","date":"2026-01-09","type":"pipeline","source":"Stock Titan","summary":"Biotech lands $26M to advance new treatments for heart and metabolism - Stock Titan","headline":"Biotech lands $26M to advance new treatments for heart and metabolism","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMitgFBVV95cUxQY0tiYVhzRE1fbl9EMG8wUnNPZUlwWG5SQjVXQldfY3RNMUM2Rmx1Vk5PcWFuNUdwWjBlcnJvaVhJZE5FZ01uNWZYTFJpMFBLWnJjcHdEdW0yY1Q2X0tTeEJWTURnWDdIeEFhUjBQSmJHOE1fS3BVNmNyWnotdUNHR2hpN05wU1JBem5BS1JUYkdZTERXRktBa1BhVHY4UjJxVmlDZzFzOFJsNEk0U1NFemJ0MWs3QQ?oc=5","date":"2026-01-09","type":"pipeline","source":"GlobeNewswire","summary":"iBio Announces $26 Million Private Placement - GlobeNewswire","headline":"iBio Announces $26 Million Private Placement","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMibkFVX3lxTE8zVld5bVQweWc0QzNtaUZnRWRfWUlWSDYzbHo1V1Vqdkc4V3c3bWcwbWtjN2VWNS1Rd1E0SU1xZEdhNk11d1RTMk9DeHF1bEl4b0tIVnZ0SWtWUmlIT0VVRWc5cTRFcUdiMEp4UmNn?oc=5","date":"2025-12-08","type":"pipeline","source":"StocksToTrade","summary":"iBio Rockets: Is It a Mirage or Real Boost? - StocksToTrade","headline":"iBio Rockets: Is It a Mirage or Real Boost?","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2025-11-13","type":"pipeline","source":"simplywall.st","summary":"It's Unlikely That The CEO Of iBio, Inc. (NASDAQ:IBIO) Will See A Huge Pay Rise This Year - simplywall.st","headline":"It's Unlikely That The CEO Of iBio, Inc. (NASDAQ:IBIO) Will See A Huge Pay Rise This Year","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMitgFBVV95cUxNeDlFWkVCcE5LWHcyVTN4SWRELXlILVl2WWM1a0pqVlh6TkdtVHcwRzFYLWNGc3ZJeDc5Mk9GUGFRdU1nUmpTaHJtQ0FGdC1mYzZfYjVYM1FQVlByaHNFbUZXUnNCbkNvVnNrc3ZadXpvQzFUaDVzelVUNXVUUzdkX3lXeHNVdmZJT3hWSDdFRUNhMlVZN01aWHFtZDBMeHVPVE5uNExLY2VBc0RhaWFCeGt5S1Vqdw?oc=5","date":"2025-10-23","type":"pipeline","source":"Stock Titan","summary":"iBio (NASDAQ: IBIO) fireside chat Nov 10 at 8:30 a.m. ET on obesity pipeline, Guggenheim - Stock Titan","headline":"iBio (NASDAQ: IBIO) fireside chat Nov 10 at 8:30 a.m. ET on obesity pipeline, Guggenheim","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMigAFBVV95cUxOUXlHZ3czQVBQUmFObUJDRFI4ZTh6WjVvZmNueUptTXAxMS1zZElrSFR1Szg2Q2tURzM1bjV2ZmNPMTNQVlA4eU5QNkYyUUd6QUZ3MjBFREFzeGVvNi1WejFiVjUxYUQwbUEtQTZ2SjlxWGtkWmc2YkVXQmdGT0dmMw?oc=5","date":"2025-09-05","type":"pipeline","source":"Business San Diego","summary":"Exclusive: Interview with iBio and How it Plans to Use New Capital from its Latest Public Offering - Business San Diego","headline":"Exclusive: Interview with iBio and How it Plans to Use New Capital from its Latest Public Offering","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiwgFBVV95cUxQS2RTWGxlQXpka3plR1Z1TzBkRHJHRzJPeWJpSHNxTXp2eVpYN2ZqUWpDQTRRM3c3LTktaEdyNUk4VjdnWXQ3cm9ybnFpaXlRMjJVbmVSSGxLZmVzVlNGeHU5RUNaVXRnXzBDb3JQX2hnazJadzJ4OEFVWDRMc1VKUlpySFlmX0s3VnFkZkVkX0RGT0Q3RFBlNkdDT0NELUgxYk1QZTF2eml5UFJkNXpINWZ6T05rakZzenFKdVFnVE1WUQ?oc=5","date":"2025-09-05","type":"pipeline","source":"San Diego Business Journal","summary":"iBio Sets Sights on Clinic for Treatments of Obesity, Heart Disease - San Diego Business Journal","headline":"iBio Sets Sights on Clinic for Treatments of Obesity, Heart Disease","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiVEFVX3lxTFBTVHpISlJNb1l0ZzllVXNUT2VYcGhkX1VWbmdUeDNwdHpNT3ZGSEcxa3RHeFZCdTUtYjJ5b2lydEpPM1hMRmphcmRCU1I2NDI1alloXw?oc=5","date":"2025-05-29","type":"deal","source":"Intellectia AI","summary":"IBIO Forecast — Price Prediction for 2026. Should I Buy IBIO? - Intellectia AI","headline":"IBIO Forecast — Price Prediction for 2026. Should I Buy IBIO?","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2025-05-11","type":"pipeline","source":"simplywall.st","summary":"Insiders Who Purchased US$655.0k Of iBio Stock May Not Have Expected 23% Tumble - simplywall.st","headline":"Insiders Who Purchased US$655.0k Of iBio Stock May Not Have Expected 23% Tumble","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiU0FVX3lxTE1zMHF0Rm43ZUsyTUlYeG1XVXI4azJNWk54MThOSnpBYVYwMmFRU251ZE1TZW9qWHkyZU5OaElyYlN5VEJWd0FBRVI5WE9DMkgzRldR?oc=5","date":"2025-04-22","type":"pipeline","source":"The Pharma Letter","summary":"AstralBio - The Pharma Letter","headline":"AstralBio","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiXEFVX3lxTE9DOXVRVU9Jb190UmR1Q3gyRU1vYjRLSlBXdFAydGI4ZFJaUzFJa2dVX1VueXczTEZWQ0VwOW1aVEJBYjZqbE1Wd2JvTFRmMnJwZW50Z3lHaFg5OC1M?oc=5","date":"2025-03-04","type":"pipeline","source":"TradingView","summary":"IBIO Stock Price and Chart — NASDAQ:IBIO - TradingView","headline":"IBIO Stock Price and Chart — NASDAQ:IBIO","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMihwFBVV95cUxObDJ0UTlDOVh2SUpabzNMQmFXSFJRbEcwaWVacEFhT0tUdzVQNkJZYnFwWmpkWUVxWU1leGtzOGtOUGNPRENQN2FsWFVwZEZYeGQzdlA0aXB5TnhxdXlqZ2JHTC02SWY0bENjQ0JMUExpUWlLenFsUzZRbHBUUjJNWXN4dGtMd00?oc=5","date":"2024-02-26","type":"pipeline","source":"Yahoo Finance","summary":"iBio Announces Sale of Preclinical PD-1 Agonist Antibody Program to Otsuka - Yahoo Finance","headline":"iBio Announces Sale of Preclinical PD-1 Agonist Antibody Program to Otsuka","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":2,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}